HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The association of patient weight and dose of fosphenytoin, levetiracetam, and valproic acid with treatment success in status epilepticus.

Abstract
The Established Status Epilepticus Treatment Trial was a blinded, comparative-effectiveness study of fosphenytoin, levetiracetam, and valproic acid in benzodiazepine-refractory status epilepticus. The primary outcome was clinical seizure cessation and increased responsiveness without additional anticonvulsant medications. Weight-based dosing was capped at 75 kg. Hence, patients weighing >75 kg received a lower mg/kg dose. Logistic regression models were developed in 235 adults to determine the association of weight (≤ or >75 kg, ≤ or >90 kg), sex, treatment, and weight-normalized dose with the primary outcome and solely seizure cessation. The primary outcome was achieved in 45.1% and 42.5% of those ≤75 kg and >75 kg, respectively. Using univariate analyses, the likelihood of success for those >75 kg (odds ratio [OR] = 0.9, 95% confidence interval [CI] = 0.54-1.51) or >90 kg (OR = 0.85, 95% CI = 0.42-1.66) was not statistically different compared with those ≤75 kg or ≤90 kg, respectively. Similarly, other predictors were not significantly associated with primary outcome or clinical seizure cessation. Our findings suggest that doses, capped at 75 kg, likely resulted in concentrations greater than those needed for outcome. Studies that include drug concentrations and heavier individuals are needed to confirm these findings.
AuthorsAbhishek G Sathe, Jordan J Elm, James C Cloyd, James M Chamberlain, Robert Silbergleit, Jaideep Kapur, Hannah R Cock, Nathan B Fountain, Shlomo Shinnar, Daniel H Lowenstein, Robin A Conwit, Thomas P Bleck, Lisa D Coles
JournalEpilepsia (Epilepsia) Vol. 61 Issue 6 Pg. e66-e70 (06 2020) ISSN: 1528-1167 [Electronic] United States
PMID32420641 (Publication Type: Clinical Trial, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2020 International League Against Epilepsy.
Chemical References
  • Anticonvulsants
  • Levetiracetam
  • Valproic Acid
  • Phenytoin
  • fosphenytoin
Topics
  • Adolescent
  • Adult
  • Anticonvulsants (administration & dosage)
  • Body Weight (drug effects, physiology)
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Levetiracetam (administration & dosage)
  • Male
  • Phenytoin (administration & dosage, analogs & derivatives)
  • Single-Blind Method
  • Status Epilepticus (drug therapy, physiopathology)
  • Treatment Outcome
  • Valproic Acid (administration & dosage)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: